ENTITY

Upstream Bio (UPB US)

4
Analysis
Health Care • United States
Upstream Bio, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. Upstream Bio serves customers in the United States.
more
Exchange Announcement • 01 Sep 2026 19:05

Current Report (Form 8-K | Period ending 2026-09-01)

Exchange Announcement • 11 Aug 2026 19:10

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 11 Aug 2026 19:05

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 11 Jun 2026 04:05

Current Report (Form 8-K | Period ending 2026-06-09)

Exchange Announcement • 13 May 2026 19:10

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x